Recherche
-
Optimal priming of poxvirus vector (NYVAC)-based HIV vaccine regimens for T cell responses requires three DNA injections. Results of the randomized multicentre EV03/ANRS VAC20 Phase I/II Trial
(PLoS Pathogens. vol. 16, n° 6, pp. e1008522, 2020-06-26)Article de revueLibre accès -
Analyzing cellular immunogenicity in vaccine clinical trials: a new statistical method including non-specific responses for accurate estimation of vaccine effect
(Journal of Immunological Methods. vol. 477, pp. 112711, 2020)Article de revue -
EpidemiOptim: a Toolbox for the Optimization of Control Policies in Epidemiological Models
(2020)Document de travail - Pré-publication -
Comparison of AUC in clinical trials with follow up censoring: Application to HIV therapeutic vaccines
(ISCB 2020 - 41th Annual Conference of the International Society for Clinical Biostatistics, ISCB 2020 - 41th Annual Conference of the International Society for Clinical Biostatistics, pl, Krakow / Virtual, 2020)Communication dans un congrès avec actes -
Influence of the Antiretroviral Regimen on the Early Changes in Plasma HIV RNA and Immune Activation at Initiation of Antiretroviral Therapy in Naïve HIV-1–Infected Patients
(Journal of Acquired Immune Deficiency Syndromes. vol. Publish Ahead of Print, 2020-12-17)Article de revue -
Public Health and Epidemiology Informatics: Recent Research Trends Moving toward Public Health Data Science
(IMIA Yearbook of Medical Informatics. vol. 29, n° 1, pp. 231-234, 2020)Article de revueLibre accès -
The impact of clopidogrel on plasma-soluble CD40 ligand levels in systemic lupus erythematosus patients: the CLOPUS phase I/II pilot study
(Joint Bone Spine. pp. 105097, 2020)Article de revue -
Correlation between blood telomere length and CD4+ CD8+ T-cell subsets changes 96 weeks after initiation of antiretroviral therapy in HIV-1-positive individuals
(PLoS ONE. vol. 15, n° 4, pp. e0230772, 2020)Article de revueLibre accès -
Comment la modélisation peut-elle aider au développement des vaccins ?
(Interstices, 2020-07-08)Article de revue -
Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial)
(Trials. vol. 21, n° 1, pp. 846, 2020-10-13)Article de revueLibre accès